The disappearance of free cholesterol in incubated serum is inhibited in some lightly heparinized subjects. This inhibition is accentuated when an emulsion of soy bean phosplmtides is added to the serum prior to incubation. The combined effect of in vivo heparin and in vitro phosphatide is the reverse of that produced by added phosphatide alone in unheparinized serum. In a limited number of experiments, the lesults with crystalline lecithin l'esembled those produced by soy bean phosphatides, but were more pronounced.
I
T has been shown 1 that the addition of plant phosphatides to serum prior to incubation results in increased disappearance of free cholesterol at 24 and 72 hours. The present report describes the influence of small doses of heparin upon this disappearance in the presence and absence of added phosphatides* of natural and synthetic origin.
PROCEDURE
A. The effect of heparin in vivo with and loilhoid in vitro addition of soy bean phosphatide. Thirteen healthy young subjects were studied. Venous blood was drawn immediately before the intravenous injection of 20 mg. of Heparin Sodium (Upjohn) and one-half hour and three hours after. It was placed in the refrigerator until the clot had formed, after which the serum was removed. Sodium ethyl mercurithiosalicylate was added as a preservative 1 and the sample was divided into five portions. Free and From tlio I'jvuiiston Hospital Research Laboratory, and the Department of Medicine, Northwestern University Medical School, Evanston, Illinois.
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Received for publication: October 7, 1954 . * RAS Lecithin, Glidden, or crystalline synthetic l-alplui dimyristoyl lecithin, as indicated in the text and tables. The latter was kindly supplied by Dr. Erich Baer, in whose laboratory it was synthesized. total cholesterol concentrations in each portion were determined in duplicate by the method of Sperry.
1
The fh'st portion was examined at once, after volumetric adjustment with 0.2 ml. of water per ml. of serum, to provide control data. The remaining four portions were ti'eated as follows. 0.2 ml. of an aqueous emulsion of soy bean phosphatides (2% w/v) per ml. of serum was added to each of a pair and 0.2 ml. of water per ml. of serum to each of the other pair, bringing the volumes uniformly to 2.4 ml. All were sealed in glass vials and incubated at 37 C. Cholesterol fractions in one of each pair were determined at 24 hours and in the others at 72 hours. Since the total cholesterol remains unchanged under these conditions, only the free cholesterol values are reported in Table 1 . Each figure represents the average of duplicates. As indicated in the Table, some of the subjects were fasting and some were not.
B. Duration of the heparin-phosphatide effect. Fourteen healthy young subjects were studied. All details of the method were as given above with the following exceptions. The dose of heparin was 25 mg. Blood samples were drawn immediately before the injection of heparin and at 5, 15, 30, 45, 60, 90 , and 120 minutes thereafter. Incubation time was 72 hours only. All incubated samples contained added phosphatide as specified previously. The data are given in Table 2. C. Identification of Uie phosplialide influence with crystalline lecithin. Water emulsions of 1-alpha demyristoyl lecithin in varying concentrations were prepared by prolonged shaking. These were used in place of the soy bean phosphatide emulsion. Serum was drawn just before and five minutes after the intravenous injection of 25 mg. heparin. All other details of the method were as given in (A). Four experiments were done. The subjects were healthy 166 PHOSPHATIDE, HEPARIN AND SERUM CHOLESTEROL 
±4.4
Presence or absence of added phosphatide indicated by + or -at head of column. All data given in mg% free cholesterol present. * Fasting subjects. young men in the fasting state. The results are given in Table 3 .
RESULTS
A. The pre-heparin group of data in Table 1 shows an average increase in the disappearance of free cholesterol in the presence of phosphatide at 72 hours of incubation. Occasional fairly wide departures from the average are seen. The individual data are generally consistent in showing that added phosphatide does alter the disappearance of free cholesterol and that this alteration is more often in the direction of increased disappearance. The absence of this effect at 24 hours is contrary to our previous experience and may be due to lot differences in the phosphatide mixture.
In samples taken one-half hour after heparin, the averages show slight but significant inhibition of disappearance of free cholesterol in the absence of phosphatide and marked inhibition in its presence. This difference is more apparent at 72 than at 24 hours. It is of primary interest that phosphatide, which increases the disappearance of free cholesterol in incubated serum without heparin, shows reversal of this action in the same subject after heparin. It is clear that the reversal applies only to the disappearance effect in the system. Hydrolysis of esterified cholesterol does not occur; the original ratio of combined/free cholesterol in the unincubated control samples is never inverted. Some disappearance of free cholesterol continues to occur upon incubation but this disappearance is not only much less than occurs in the same subject without heparin in the presence of phosphatide, it is also less than ocelli's in the presence of heparin without phosphatide. These relationships are graphically demonstrated in figure 1 . The opposite actions of phosphatide suggest that its influence is related in some way to the physical composition of the serum. The increase in the standard deviations in the half-hour group of PHOSPHATIDE, HEPARLX AND SERUM CHOLESTEROL data, compared with the pre-heparin group, reflects the variable response of individuals to heparin. This variability is most apparent in subject D, whose performance was conspicuous for persistent reversal of the usual phosphatide effect in all sample classes and, consistent with this reversal, inversion of the usual heparinphosphatide inhibition at one-half hour. This subject was unlike all others, fasting or nonfasting. It is improbable that the results here were due to reagent difference since the same lot of phosphatide showed "normal" activity in other subjects. This and smaller deviations from the average give the impression that the individual response either to in vitro phosphatide or to in vivo heparin is subject to unknown influences. The fair agreement of results among individuals in this series may be attributable to an "average condition" of these influences in health. The three-hour results essentially reproduce the pre-heparin results, indicating that the influence of heparin in the dose employed is spent at that time.
In the post-heparin samples, the variation of free cholesterol in unincubated samples from the same subject is beyond the range of error of the method in some instances. This instability is unexplained. That the variation occurred in both directions is shown by comparing the averages of unincubated samples throughout the experiment.
B. In table 2, where the heparin-phosphatide effect is given as a function of time, the maximal effect appears within five minutes after heparin. This persists for thirty minutes and falls off smoothly thereafter. Continued effect at two hours agrees with the findings in the first experiment. No appreciable difference appears between fasting and nonfasting subjects.
C. The results with crystalline lecithin are given in table 3. The pre-heparin samples show increased disappearance of free cholesterol upon incubation in the presence of pure lecithin at all concentrations used. The degree effect varies. "J. D." shows marked disappearance at 24 hours but maximal effect only at 72 hours. "C. Z. 3/1/54" approximates 100 per cent disappearance at 24 hours in the presence of lecithin as compared with 50 per cent disappearance in its absence. The data for these two subjects suggest that the concentrations of lecithin employed covered the optimum range. An effort was therefore made in the next two subjects to find the minimum effective concentration. As shown in the table, decreasing concentrations below the optimum were associated with progressive loss of effect. "C. Z. 6/7/54" showed almost complete loss of effect at 0.26 mg. of lecithin per ml. of serum, but in the case of "L. R." it is apparent that an even more minute concentration of lecithin would be required to reach the same point.
Comparison of the paired data for each subject shows that within five minutes after the injection of heparin the lecithin effect is diminished regularly. This is consistent with an apparent tendency for heparin to inhibit the disappearance of free cholesterol even in the absence of lecithin. have demonstrated serum clearing with even smaller doses. Graham and his associates 6 have reported clearing of Sf 20-100 lipoprotein species within 15 minutes after heparin in doses like those used in the present work. The agreement of these findings as to time and dose with our own results suggests that the effect we have seen could be related to the clearing process. It is inconsistent that the heparin effect observed by Graham persisted for over six hours while ours was gone at approximately three hours. It is possible that these parallel effects are only partially related, if at all. Swank and his associates 7 report chromatographically demonstrable alteration of protein patterns following heparin. It could be inferred that the effects reported here are due to interference with the activity of enzymes. 8 ' 9 Anderson and Fawcett 10 have postulated the formation of heparin-phospholipid complexes following the administration of heparin. It could be assumed that the in vivo product of heparin in the serum thus blocks the usual effect of added phosphatide in the in vitro system. This assumption would not explain the observations fully, since added phosphatide in heparinized sera produces greater inhibition of disappearance than is seen in the same samples without added phosphatide. The inhibition produced by heparin alone is inconstant and relatively small, while that produced by heparin plus phosphatide is more nearly constant and relatively large.
The results with crystalline lecithin agree with those produced by the phosphatide mixture. The only difference is quantitative. Pure lecithin is more active, the ratio being about 1:4 by weight. The small quantity of lecithin required for an effect suggests a high degree of specificity. Expressed in clinical terms, subject "C. Z." showed almost complete disappearance of free cholesterol when the in vitro level of senim lecithin was raised by 80 mg per cent and continued to show the trend when the increment was50 mg. per cent. "L.R." showed significant results when the increment was only about 30 mg. per cent. This close relationship has particular interest because of the following considerations. Naturally occurring serum lecithin is present in relatively large concentrations. 11 ' 12 " This concentration is stably related to the serum cholesterol concentration in health. A positive shift in the ratio between the two has been correlated with the incidence of atherosclerosis. 14 ' 16 The experiments in the present report produced, in vitro, a negative shift of the cholesterol/ phosphatide ratio, with marked influence upon one aspect of cholesterol metabolism. The role of lecithin in this study is conjectural. Ahrens and Kunkel" in experiments that produced a decline in naturally occurring serum phospholipid, found that as phospholipid diminished, serum lipid particles tended to coalesce. They suggested that with a given concentration of total serum lipid, the greater the lecithin concentration, the smaller the lipid particle which may exist. It follows that the increased disappearance of free cholesterol produced by added lecithin in the present study may simply reflect an increase in reactive interface.
The relationship of in vivo heparin to the system studied remains obscure. With heparin the spontaneous disappearance of free cholesterol is diminished and the potentiating effect of lecithin upon this disappearance is diminished in the higher lecithin concentrations and nullified in the lower ones. Further speculation is unjustified at this time.
Bragdon and Havel 17 surmise from their studies. on antiheparin agents that heparin and/or heparinoids have a physiologic role in the transport of blood lipids. The results of the present experiments may provide fragments of information fitting such a surmise. Admitting a lack of precise chemical identity for the reagents employed in our studies, the system used is analogous to that which exists in circulating blood, minus homeostatic influences.
SUMMARY
Added phosphatide alone increases the disappearance of free cholesterol in incubated serum. Circulating heparin alone tends to inhibit the disappearance of free cholesterol in incubated serum. Yet, added phosphatide after intravenous heparin increases the heparin PHOSPHATIDE, HEPARIX AND SERUM CHOLESTEROL effect (that is, it more strongly inhibits the disappearance of free cholesterol); hence, the effect of phosphatide alone is reversed.
The results with crystalline lecithin differed from those with the soy bean phosphatide mixture only in being more pronounced.
